My "second love" with the spike"
Release time:
2020-07-22
My "Second Love" with Peak
Remember that it was 2002 5# August 8 . I first reported to Peak Pharmaceutical, and my destination was Linhai Jianfeng Haizhou Pharmaceutical Factory, a subsidiary factory of the pharmaceutical industry. At that time, Haizhou Pharmaceutical had overgrown weeds at the factory gate, and "desolation" was the first impression it gave me. In the old factory area, I only stayed for one month, and the next month I went to Du Qiao to build a new factory. Although some details can't be remembered now, the "weeding incident" that occurred that month is still impressive. At that time, the greening work in the factory was contracted by an employee, because the enterprise was facing relocation due to poor efficiency, the mentality of the employees was floating, and some managers did not dare to take care of it, so I pulled out a handful of weeds and put them on the employee's desk, forcing him to pull the weeds. Although this seemed unpleasant at the beginning, it was the so-called "no fight, no acquaintance", and later this employee became my good friend. This employee's name is Wu Shunfa. Some old employees may still remember that he is also an excellent salesman.
2002 5 to 2005 was my first working experience in Jianfeng Pharmaceutical, mainly responsible for preparing for the construction of a new factory. Those two and a half years can be described as a turbulent period for the pharmaceutical industry. From the pharmaceutical company to Haizhou Pharmaceutical, the leadership team changed several times. However, with the joint efforts of my colleagues and I, we still completed the preparation for the new factory and the relocation of equipment, and successfully passed the bulk drug GMP examination in 5 before the deadline for passing the GMP certification stipulated by the State Food and Drug Administration in 2004 . That experience meant a lot to my personal growth, and I'm always grateful for it. Although later for some reason left the peak, but in the peak of the day, left me are good memories. Although the conditions at the time of preparation were very poor, lunch was often a bowl of pickle soup in the canteen of the construction team, but when the leaders at all levels of the company came to inspect the work, they always cared about our life, so that I still miss the taste of braised three green crabs. More than ten years have passed in a flash. Although the external environment has changed greatly and the production of peak pharmaceutical preparations has developed and expanded, the development of API has returned to the starting point.
, when there was another chance to return to the peak family, I decisively chose to return. Because I have been wandering outside for many years, I still can't forget the surprise of receiving a "good wife award" at the end of 2002 and the happiness of my family, as well as the careful guidance of the pharmaceutical project department to our preparatory team that year. It's the spikes that help me grow. Besides, in the more than ten years since I left the peak, the group leaders have visited me many times during the inspection and exchange of peer companies, which fully reflects the humanistic feelings of a listed company. Now, I have returned to work in Peak Pharmaceutical for more than two years. This is still the peak I am familiar with, but it is a little strange. The perfect enterprise system is not the same as that of that year. This time, as the person in charge of the pharmaceutical preparation for the establishment of the API business department, I got more help from peak managers during the investment inspection work of one and a half years. No matter the concept of leading investment and development of enterprises, or the quality of professionals, I feel deeply. In particular, the "innovative" spirit of enterprise, let me have a real experience. I understand that the slightly conservative peak in the original impression actually contains deep innovation genes. The new generation of leaders is leading the peak to rejuvenate and move towards new glory.
Now, our Jianfeng Pharmaceutical Co., Ltd. has regained its platform for the development of API business-Shanghai Beika Pharmaceutical Technology Co., Ltd., and has two Anhui factories. I am full of confidence in the future development of the API production base. Up to now, the peak has gone through
years of development. I write this article to my small partners and new colleagues now. I also use this to encourage us to contribute to the "100-year peak. (Lou Xiaohua)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11